Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
-9,20%
3-year Growth Rate
R
1/5
3-year Risk Analysis
O
39,04%
Outlook 12/26
W
28,55%
Margin of safety
T
89,09%
Analyst Price Target
H
DOWN
50-week EMA Trend
It is not possible to show the GROWTH analysis for a period of five years. Showing the analysis for a period of three years instead.
Company Info
EPS Growth 3Y
-29,29%
Revenue growth 3Y
-39,88%
Price growth 3Y
0,00%
Market Cap
€0,01 B
Long-Term Debt
€0,00 B
Quarterly earnings
06/26/2026
Dividend
€0,00
Dividend Yield
0,00%
Industry
Country
ISIN Number
Laboratorio Farmaceutico Erfo S.p.A. Price Chart (EUR)
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
€2,08
89.09%
Last Update: 05/20/2026
Analysts: 1
Highest Price Target €2,08
Average Price Target €2,08
Lowest Price Target €2,08
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
Laboratorio Farmaceutico Erfo ...
BIT:ERFO
|
-36,90% | -40,11% | 3,21% | -9,20% | 1/5 | 39,04% | 28,55% | 82,46% | DOWN |
